SINTX Technologies Announces New Antiviral Test Results

NEXT STORY
Global Point of Care Diagnostics Market to Rise at 6.6% CAGR to Reach US$ 28,379.6 Mn by 2026, Increasing Disposable Incomes of People Worldwide Promoting Growth, says Fortune Business Insights
PREV STORY
Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chembio Diagnostics Reports First Quarter 2018 Financial Results

MEDFORD, N.Y., May 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

author_avatar
NASDAQ Market News

Novartis drug crizanlizumab shown to prolong time to patients’ first sickle cell pain crisis in subgroup analysis of SUSTAIN study

Investigational therapy crizanlizumab (SEG101, formerly SelG1) approximately doubled the time to first on-treatment sickle ...

author_avatar
NASDAQ Market News

Ohr Pharmaceutical Announces Appointment of David Brown, MD as Chair of Phase 3 Clinical Program Steering Committee

NEW YORK, May 02, 2016 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology ...

author_avatar
NASDAQ Market News